Catheter Ablation as an Early Rhythm-control Strategy in Patients with Atrial Fibrillation and Heart Failure

AF and heart failure (HF) commonly coexist, and this significantly increases patient morbidity and mortality. Maintaining sinus rhythm is a key treatment goal, as it helps prevent HF progression, improves quality of life and reduces cardiovascular mortality. Catheter ablation (CA) has emerged as an effective and preferred alternative to antiarrhythmic medications for rhythm control in patients with AF and HF. Multiple studies have demonstrated the superiority of CA over medical therapy for maintaining sinus rhythm and improving left ventricular function in the HF population, particularly those with reduced left ventricular ejection fraction. Additionally, CA is associated with a low complication rate due to advancing technology and is cost-effective. With growing evidence and endorsement from recent guidelines, clinical practice has shifted towards early CA in patients with AF and HF. Prioritising early intervention represents a proactive approach to improving long-term outcomes.